Back to search

Peptide record

TPDB21309

Antibacterial Anticancer Toxicity standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB21309
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 15-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
Sequence
IKKIIKIIKKIIKKI
Physicochemical Analysis
C90H174N22O16
ARNDCEQGHLMFPSTWYV
I
1820.51
11.29
7
0
8
+7
4.45
0.580
208.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
8
I
0
L
7
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 8 L: 0 K: 7 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
15
C90H174N22O16
1820.51
11.29
+7
4.45
0.580
Evidence Records 6 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
10% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Highly selective performance of rationally designed antimicrobial peptides based on ponericin-W1. | Biomater Sci | 2022
Evidence 2 Activity

Activity

15% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
15% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Highly selective performance of rationally designed antimicrobial peptides based on ponericin-W1. | Biomater Sci | 2022
Evidence 3 Activity

Activity

IC50
Toxicity
26.1 µM
Cytotoxic
IC50 | 26.1 | µM | target cell: Human foreskin fibroblasts (HFF)

Target

Human foreskin fibroblasts (HFF)

Source & Reference

NA
DBAASP
Anticancer effect of rationally designed α-helical amphiphilic peptides | Colloids Surf B Biointerfaces | 2022
Evidence 4 Activity

Activity

10% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
10% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anticancer effect of rationally designed α-helical amphiphilic peptides | Colloids Surf B Biointerfaces | 2022
Evidence 5 Activity

Activity

25% Hemolysis
Toxicity
200 µM
Hemolytic Cytotoxic
25% Hemolysis | 200 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anticancer effect of rationally designed α-helical amphiphilic peptides | Colloids Surf B Biointerfaces | 2022
Evidence 6 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Colloids Surf B Biointerfaces. 2022 Dec 220:112850.